Counterfeit medicines, a threat to public health, how can the pharmaceutical industry contribute to protect patient safety worldwide?

被引：0

作者：

Atlani, C. ^{[1
]}

机构：

[1] Sanofi, Anticounterfeit Coordinat, Paris, France

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2013年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：20 / 20

页数：1

共 50 条

[1] How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil
da Fonseca, Elize Massard
[J]. GLOBAL PUBLIC HEALTH, 2018, 13 (04) : 489 - 502
[2] The Global Counterfeit Drug Trade: Patient Safety and Public Health Risks
Mackey, Tim K.
Liang, Bryan A.
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) : 4571 - 4579
[3] The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance
Bergstrom, Richard
[J]. DRUG RESISTANCE UPDATES, 2011, 14 (02) : 77 - 78
[4] How green chemistry can contribute to pharmaceutical industry sustainability: Accomplishments and opportunites
Cue, Berkeley W.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[5] Breaking Health Barriers: How Can Public Libraries Contribute?
Rubenstein, Ellen L.
[J]. PUBLIC LIBRARY QUARTERLY, 2016, 35 (04) : 331 - 337
[6] Rethinking Opioid Prescribing to Protect Patient Safety and Public Health
Alexander, G. Caleb
Kruszewski, Stefan P.
Webster, Daniel W.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (18): : 1865 - 1866
[7] The counterfeit drug invasion: How drug reimportation unjustifiably poses a threat to the health of the US public
Rosenfield, TA
[J]. UNIVERSITY OF PENNSYLVANIA JOURNAL OF INTERNATIONAL ECONOMIC LAW, 2004, 25 (03): : 1047 - 1077
[8] Adverse drug reactions-how patient reports can contribute to patient safety
Kieve, M.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 114 - 115
[9] Genuine medicine? Why safeguarding the pharmaceutical supply chain from counterfeit drugs with RFID is vital for protecting public health and the health of the pharmaceutical industry
Wyld, David
[J]. COMPETITIVENESS REVIEW, 2008, 18 (03) : 206 - +
[10] Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health
D'Hooghe, Thomas
[J]. HUMAN REPRODUCTION, 2017, 32 (08) : 1549 - 1555

← 1 2 3 4 5 →